The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease

Chin-Song Lu(SAIC-GM (China)), Vincenzo Bonifati(University Medical Center), Christan F. Rohé(SUNY Upstate Medical University), Hsiu‐Chen Chang(Tao Yuan General Hospital), Guido J. Breedveld(SUNY Upstate Medical University), Erik Simons(Erasmus University Rotterdam), Alessio Di Fonzo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Thomas Gasser(Hertie Institute for Clinical Brain Research), Yi‐Hsin Weng(Chang Gung Memorial Hospital), Ben A. Oostra(Erasmus MC), Nobutaka Hattori(Juntendo University Hospital), Yah‐Huei Wu‐Chou(Chang Gung Memorial Hospital), Rou-Shayn Chen(Chang Gung Memorial Hospital)
Parkinsonism & Related Disorders
October 27, 2005
10.1016/j.parkreldis.2005.09.003
Cited by 79

Related Papers

MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
|Nature|1998|5.2k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
|Nature Genetics|2000|2k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k